Weight-Loss Drugs Estimated to Save Airlines Millions

(https://archive.ph/EHH21)

Obesity drugmaker’s expansion raises dominance worries for Denmark

Soaring sales for Novo Nordisk’s products mean market capitalisation now exceeds country’s GDP

“The way that we look at it is that in Denmark we have a two-speed economy: the pharmaceutical industry — and the rest,” said Thomas Harr, chief economist at Denmark’s central bank. “The risk is that you think the economy is performing better than it is.”

“Novo is so fantastically successful, and that is great for it and its shareholders. But for Denmark, I worry about what happens if it goes wrong,” said a leading business executive. “Finland ended up with a lost decade when Nokia had its problems.”